10 Best Integrated Utility Stocks To Invest In Right Now

If you're feeling good about the market, you're not alone. Take my hand as we go over some of this week's more uplifting headlines.

1. GM takes the wheel
The acquisition of H.J. Heinz opened up a vacancy in the S&P 500, and General Motors (NYSE: GM  ) is pulling in for the keys.

The country's leading automaker was booted from the widely tracked index four years ago at the height of the government-funded bailout and GM's own bankruptcy reorganization.

The four-year lull was well-earned, but now that a streamlined GM is growing and squarely profitable it's a no-brainer to welcome the bellwether back to the S&P 500.

2. Amazon wants to direct
Amazon.com (NASDAQ: AMZN  ) continues to line up programming that viewers won't find on its larger rival's platform.

A week after revealing five pilots that it will be green-lighting for full seasons, the leading online retailer has landed an even more magnetic content deal with Viacom. Amazon now has a multiyear deal in place with Viacom's Nick Jr., Nick, MTV, and Comedy Central, covering 3,900 episodes across 250 seasons.

Best Defense Companies To Own In Right Now: Diamond Foods Inc.(DMND)

Diamond Foods, Inc., a packaged food company, engages in processing, marketing, and distributing snack products, as well as culinary, in-shell, and ingredient nuts. Its snack products include glazed nuts, roasted and mixed nuts, breakfast trail mix products, microwave popcorn products, and potato and tortilla chips. The company?s culinary nuts comprise shelled nuts, pegboard nuts, and harvest reserve premium nuts. Its in-shell nuts consist of uncracked nuts and mixed nuts; and ingredient/food service products include shelled and processed nuts, and custom-processed nuts. The company offers its products under the Emerald, Pop Secret, Kettle, and Diamond of California brand names. It markets its culinary nuts to individuals, who prepare meals or baked goods at home; and ingredient and food service nuts to food processors, restaurants, bakeries, and food service companies and their suppliers. Diamond Foods, Inc. sells its products directly to retailers, such as national groce ry stores, club stores, mass merchandisers, and drug store chains; and indirectly through wholesale distributors, who serve independent and small regional retail grocery store chains and convenience stores. The company offers its products in the United States, the United Kingdom, Germany, the Netherlands, Spain, Italy, Canada, South Korea, Turkey, and Japan. Diamond Foods, Inc. was founded in 1912 and is based in San Francisco, California.

Advisors' Opinion:

• [By Suravi Thacker]

  On one hand, ConAgra ramped up its advertising and on the other its peer Diamond Foods (DMND) has cut down on its promotional spend. The unfavorable impact of cutting down on marketing spend showed up on Diamond Foods��recent quarter as well as on its stock price. The stock price performance of the three industry players in the last five years shows that ConAgra is doing well.

10 Best Integrated Utility Stocks To Invest In Right Now: Titan Pharmaceuticals Inc (TTNP.OB)

Titan Pharmaceuticals, Inc., incorporated in February 1992, is a biopharmaceutical company developing therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of products that include Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders, and Spheramine for the treatment of advanced Parkinson�� disease. Titan Pharmaceuticals is directly developing its product candidates and also utilizing corporate partnerships, including a collaboration with Bayer Schering Pharma AG, Germany (Bayer Schering) for the development of Spheramine to treat Parkinson�� disease, and Vanda Pharmaceuticals, Inc. (Vanda) for the development of iloperidone for the treatment of schizophrenia and related psychotic disorders.

Probuphine

Probuphine is the first product to utilize the Company�� ProNeura long-ter m drug delivery technology. Probuphine is designed to provide continuous, long-term therapeutic levels of the drug buprenorphine, an approved agent for the treatment of opioid addiction. In December 2007, the Company completed enrollment in a randomized, double-blind, placebo-controlled, multi-center Phase III clinical study of Probuphine in the treatment of opioid addiction. This 150 patient study, which is being conducted in the United States, will evaluate the safety and effectiveness of treatment with Probuphine versus placebo in reducing opioid addiction over 24 weeks of treatment. This study is part of a registration directed program intended to obtain marketing approval of Probuphine for the treatment of opioid addiction in Europe and the United States.

Iloperidone

Iloperidone was evaluated in a Phase III program comprising over 3,500 patients at more than 200 sites in 24 countries, administered and funded by Novartis Pharma AG (Novartis). In three completed efficacy studies conducted by Novartis, ! i! loperidone statistically reduced the symptoms of schizophrenia compared to placebo. Iloperidone has also been investigated in three 12-month safety studies, which confirm safety and tolerability. A dose dependent increase in the Q-T Corrected (QTc) interval was observed and investigated further in a clinical study, and no clinically significant adverse events were observed. In September 2007, Vanda submitted a new drug application (NDA) with the United States Food and Drug Administration (FDA) for iloperidone. The NDA for iloperidone was officially accepted for review by the FDA in November 2007.

Spheramine

Spheramine is a cell-based therapeutic that utilizes the Company�� cell-coated microcarrier (CCM) technology, which enables the development of cell-based therapies for minimally invasive, site-specific delivery to the central nervous system of therapeutic factors precisely where they are needed. Spheramine consists of microcarriers coated wit h human retinal pigment epithelial cells that are intended to enhance brain levels of dopamine, a neurotransmitter deficient in certain brain regions in Parkinson�� disease, leading to movement disorders. Preclinical studies have demonstrated the preliminary efficacy and safety of Spheramine, including blinded studies in a primate model of Parkinson�� disease. In June 2007, enrollment was completed in a current multi-center, randomized, double-blind, placebo-controlled clinical trial of Spheramine in Parkinson�� disease. This Phase IIb clinical study enrolled 71 patients with advanced Parkinson�� disease (Hoehn and Yahr Stages III and IV) to further evaluate the efficacy, safety, and tolerability of Spheramine.

Bayer Schering, the Company�� corporate partner for worldwide development and commercialization of Spheramine, is funding the clinical development program for Spheramine. Under an agreement, Bayer Schering has received exclusive, worldwide deve lopment, manufacturing and commercialization rights, an! d, in! ad! dition! to the clinical and manufacturing development funding and milestone payments, Bayer Schering will pay Titan Pharmaceuticals a royalty on future product sales.

Advisors' Opinion:

• [By C.R. Jackson]

  Fanapt was discovered by Hoechst Marion Roussel in 1995 as a novel atypical antipsychotic agent. Hoechst was a German life-sciences company that became Aventis Deutschland after its merger with France's Rhône-Poulenc in 1999. When the company joined with Sanofi-Synthélabo in 2004, it became a subsidiary of the Sanofi-Aventis (SNY) the French pharmaceutical conglomerate. In 1997, Hoechst sold the research rights to Titan Pharmaceuticals (TTNP.OB). Then Titan quickly sold the worldwide rights to Novartis in 1998. Novartis then sold the Phase 3 development rights for loperidone to Vanda in 2004. Vanda originally attempted to get FDA approval for Fanapt in 2008, but the FDA refused to approve iloperidone. The agency required an additional clinical trial.

10 Best Integrated Utility Stocks To Invest In Right Now: Bemis Company Inc (BMS)

Bemis Company, Inc., incorporated on May 18, 1885, is a manufacturer of packaging products and pressure sensitive materials. The Company's business activities are organized around its three reportable business segments, U.S. Packaging , Global Packaging and Pressure Sensitive Materials. The majority of the Company�� products are sold to customers in the food industry. Other customers include companies businesses, such as chemical, agribusiness, medical, pharmaceutical, personal care, electronics, automotive, construction, graphic industries and other consumer goods. In July 2013, Bemis Company Inc acquired all of the common stock of Foshan New Changsheng Plastics Films Co., LTD.

The Company�� flexible packaging businesses has a technical base in polymer chemistry, film extrusion, coating, laminating, printing, and converting. The Company�� pressure sensitive materials business specializes in adhesive technologies. On August 22, 2012, the Company acquired two flexible packaging businesses in Australia and New Zealand.

U.S. Packaging segment

The U.S. Packaging segment represents all food, consumer, and industrial products packaging-related manufacturing operations located in the United States. This segment manufactures multilayer polymer, blown and cast film structures to produce packaging sold for food and personal care product applications as well as non-food applications. Additional products include custom thermoformed packaging, and multiwall paper bags. Markets for these products include processed and fresh meat, liquids, frozen foods, cereals, snacks, cheese, coffee, condiments, candy, pet food, bakery, seed, lawn and garden, tissue, fresh produce, personal care and hygiene, disposable diapers, agribusiness, and minerals. This segment has 35 manufacturing plants located in 16 states, of which 32 are owned directly by the Company or its subsidiaries and three are leased from outside parties.

Global Packaging segment

The ! Global Packaging segment includes all packaging-related manufacturing operations located outside of the United States as well as global medical device and pharmaceutical packaging manufacturing operations. This segment manufactures multilayer polymer, blown and cast film structures to produce packaging sold for a variety of food, medical, pharmaceutical, personal care, and industrial applications. Additional products include injection molded plastic and folding carton packaging. Markets for these products include processed and fresh meat, liquids, snacks, cheese, coffee, condiments, candy, bakery, tissue, fresh produce, personal care and hygiene, disposable diapers, agribusiness, pharmaceutical, and medical devices. This segment has 32 manufacturing plants located in three United States, the Commonwealth of Puerto Rico, and ten non-United States countries, of which 26 are owned directly by the Company or its subsidiaries and six are leased from outside parties.

Pressure Sensitive Materials segment

The Pressure Sensitive Materials segment is a global manufacturer of pressure sensitive adhesive coated paper and film substrates sold into label, graphic, and technical product markets. Products for label markets include narrow-Web rolls of pressure sensitive paper, film, and metalized film printing stocks used in high-speed printing and die-cutting. Products for graphic markets include pressure sensitive films used for decorative signage through computer-aided plotters, digital and screen printers, and photographic overlaminate and mounting materials including optically clear films with built-in ultraviolet (UV) inhibitors. Products for technical markets include micro-thin film adhesives used in delicate electronic parts assembly and pressure sensitive applications utilizing foam and tape based stocks to perform fastening and mounting functions. This segment has seven manufacturing plants located in three states and two non-United States countries, all of which are owned directly b! y the Com! pany or its subsidiaries.

The Company competes with Amcor Limited, Berry Plastics Corporation, Bryce Corporation, Exopack Company, Hood Packaging Corporation, Printpack, Inc., Sealed Air Corporation, Sonoco Products Company, Wihuri OY, Winpak ltd, 3M, Acucote, Inc., Avery Dennison Corporation, FLEXcon Corporation, Green Bay Packaging Inc., Ricoh Company, Ltd., Ritrama Inc., Spinnaker Industries, Inc., Technicote Inc., UPM-Kymmene Corporation, and Wausau Coated Products Inc.

Advisors' Opinion:

• [By The Part-time Investor]

  The following stocks met the criteria in January of 2008 and were put into the initial portfolio:

  Abbot Labs (ABT)Advanced data processing (ADP)Associated Banc-Corp (ASBC)Bank of America (BAC)BB&T Corp. (BBT)Bemis Company (BMS)Anheuser Busch (BUD)The Chubb Corporation (CB)Clorox (CLX)Comerica Inc. (CMA)Diebold Inc. (DBD)Emerson Electronics (EMR)First Dollar Corp. (FDO)First Third BanCorp. (FITB)Gannett Co, Inc. (GCI)General Electric (GE)Hershey (HSY)Illinois Tools Works (ITW)Johnson and Johnson (JNJ)Leggett and Platt (LEG)Eli Lilly (LLY)La-Z-Boy (LZB)McDonald's (MCD)Marsh and Ilsley (MI)M&T Bancorp (MTB)PepsiCo (PEP)Pfizer (PFE)Procter & Gamble (PG)Pentair Ltd. (PNR)Regions Financial Corp. (RF)Rohm and Haas (ROH)RPM International (RPM)Sherwin Williams (SHW)Sysco Corp. (SYY)UDR Inc. (UDR)

  Historical quotes were taken from Yahoo Finance. $10,000 was put into each position, to the nearest whole share, so a total of $349,262.89 was invested. From 1/15/08 through 5/16/13 all dividends were reinvested back into the stock that paid them. If a dividend cut was announced, that stock was sold on the ex-div date of the new, lower dividend.

• [By Jessica Alling]

  Leaders and laggards
  Merck (NYSE: MRK  ) is at the top of the class this morning with a 5.19% gain following some extremely encouraging news about its latest experimental drug,�lambrolizumab. Aimed at unleashing the powers of a patient's own immune system, the drug disables the immune system cells' prevention method that curbs its attack on cancer cells -- a protein called the programmed death 1 receptor, or PD-1. Merck's drug has shown a 38% rate in tumor reduction in patients with advanced melanoma, and up to 52% in patients who received the highest dosage of the drug. Though the patients have not undergone the trial for a long enough period yet, the results are attracting attention for matching the current treatments from two Bristol-Meyers Squibb (NYSE: BMS  ) drugs, Yervoy and nivolumab, with potentially milder side effects. The news is great for Merck investors, as the company has only played a small part in oncology treatments to date.

• [By Rich Duprey]

  Looking to increase its presence and market share in Asia, specialty packaging maker Bemis (NYSE: BMS  ) announced today it was acquiring a Chinese manufacturer of specialty films, Foshan New Changsheng Plastics Films.�

10 Best Integrated Utility Stocks To Invest In Right Now: Elisa Oyj (ELI1V)

Elisa Oyj is a Finland-based Company engaged in the provision of Information and Communication Technology (ICT) services in Finland and Estonia. The Company operates within two business segments: Consumer Customers and Corporate Customers. The Consumer Customers segment provides consumers and households with telecommunications services, such as voice and data services. The Corporate Customers segment provides to the corporate and community customers voice and data services, ICT solutions and contact center services. All the services are provided under the Elisa and Saunalahti brands. The Company�� global alliance partners are Vodafone and Telenor. The Company operates through its subsidiaries, including Appelsiini Finland Oy, Arediv Oy, Ecosite Oy and Elisa Eesti As, among others. Advisors' Opinion:

• [By Adam Ewing]

  A sale would provide the shareholders with cash, while potentially strengthening DNA against larger rivals Elisa Oyj (ELI1V) and TeliaSonera AB. (TLSN) The IPO could be the biggest in Finland, home of Nokia Oyj (NOK1V) and ��ngry Birds��maker Rovio Entertainment Oy, since 2005.

10 Best Integrated Utility Stocks To Invest In Right Now: Walter Energy Inc.(WLT)

Walter Energy, Inc. produces and exports metallurgical coal for the steel industry primarily in the United States. The company also produces thermal and industrial coal, anthracite, metallurgical coke, coal bed methane gas, and other related products. It principally serves electric utility and industrial customers. The company was formerly known as Walter Industries, Inc. and changed its name to Walter Energy, Inc. in April 2009. Walter Energy, Inc. was founded in 1946 and is headquartered in Birmingham, Alabama.

Advisors' Opinion:

• [By Ben Levisohn]

  Own cost-cutting winners, including Buy-rated BTU. Other companies with strong
  cost control potential include Neutral-rated [Walter Energy (WLT) and Alpha Natural Resources (ANR).]

• [By Daniela Pylypczak]

  Standard & Poor’s Rating Services announced on Thursday that it has lowered its corporate credit rating on Walter Energy (WLT) from B to B-.

  The rating on the existing senior secured debt was also lowered from B+ to B, while the senior unsecured debt was downgraded from B- to CCC+. According to the ratings firm, the downgrade and negative outlook reflects its expectations that Walter Energy’s leverage will rise to more than 10x in 2013, and that it will likely continue to be above 5x in 2014. Walter Energy has also suffered from a significant decline in coal prices, as well as weaker demand in Europe and China.

  Despite the downgrade, Walter Energy shares rallied 5.8% during Thursday’s session. Year-to-date, the stock is down 63.70%.

10 Best Integrated Utility Stocks To Invest In Right Now: Next Generation Energy Corp (NGMC)

Next Generation Energy Corp., incorporated on November 21, 1980, is an independent oil and natural gas company engaged in the exploration, development, and production of natural gas properties located onshore in the United States. On March 22, 2011, the Company purchased all of the membership interests of Knox Gas, LLC. Knox Gas, LLC owns a lease of 100 acres, which contains five drilled wells; a lease of 20.2 acres, which contains two drilled wells; a lease of 700 acres which contains no wells, and a lease of 400 acres, which contains three drilled wells.

The wells owned by Knox Gas were part of a larger field of 135 wells that was developed by Heartland Resources, Inc. and its subsidiaries (collectively Heartland), and were operated by Heartland Operating Company, Inc., a subsidiary of Heartland Resources, Inc. During the year ended December 31, 2011, the Company had no revenues.

Advisors' Opinion:

• [By Peter Graham]

  Next Generation Energy Corp (OTCMKTS: NGMC) and Dutch Gold Resources, Inc (OTCMKTS: DGRI) are the latest small cap stocks to announce their entry into the marijuana business while peer Endocan Corp (OTCMKTS: ENDO) sees some paid promotions or investor relations activities, but otherwise remains quiet. So will investors and traders alike achieve a high with any of these small cap marijuana stocks? Here is a quick reality check:

10 Best Integrated Utility Stocks To Invest In Right Now: Chesapeake Gold Corp (CHPGF.PK)

Chesapeake Gold Corp. is a mineral exploration company focusing on the discovery and development of gold-silver deposits in North and Central America. The Company�� primary asset is the Metates gold-silver project (Metates) located in Durango State, Mexico. The Company also has a portfolio of exploration properties in Mexico comprising 57,067 hectares in the states of Durango, Sinaloa, Oaxaca and Veracruz. The Escorpion property is located 85 kilometers by paved road southeast of Guatemala City. The Metates property is the undeveloped disseminated gold and silver deposits in Mexico. The property is consists of 14 mineral concessions totaling 14,727 hectares. Talapoosa property is a low-sulphidation gold/silver property in the Walker Lane gold trend of western Nevada, approximately 45 kilometers east of Reno. The property consists of 535 unpatented lode mining claims and seven additional fee land sections which cover 10,780 hectares. Advisors' Opinion:

• [By Hebba Investments]

  Therefore the situation is still very bullish for investors in physical gold and the gold ETFs (GLD, CEF, and PHYS). Investors interested in leveraging this situation into higher potential profits may also consider buying gold miners such as Randgold (GOLD), Goldcorp (GG), Yamana Gold (AUY), and any of the other gold miners. Finally, those willing to shoulder much larger risks may consider some of the exploration and micro-cap companies that offer significant profits at a high risk such as Chesapeake Gold (CHPGF.PK), Pretium Resources (PVG), Western Copper (WRN), or any other of the junior exploration companies. Though investors should keep in mind that gold mining companies and explorers do not always rise with a rising gold price - do your research before you invest in the miners.